Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Snakes (aka Chutes) and Ladders – failures and opportunities

Posted on October 13th, 2017 by in Pharma R&D

If there ever was a children’s game that would help prepare the next generation of pharmaceutical R&D scientists and researchers, it would be Snakes and Ladders (Chutes and Ladders in the US). Continue reading “Snakes (aka Chutes) and Ladders – failures and opportunities” »

Wearables in Clinical Trials: Many Benefits, and One Big Challenge

Posted on July 19th, 2017 by in Pharma R&D

 apple-watch-828827_640

The rapid development of wearable technology has the power to be a game-changer in many areas, including pharmaceutical R&D. Its most obvious use for pharma is in clinical trials, where recruiting is a frequent challenge, as is getting study participants to adhere to their therapeutic regime. Continue reading “Wearables in Clinical Trials: Many Benefits, and One Big Challenge” »

FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs

Posted on June 2nd, 2017 by in Pharma R&D

Know the rules

Since 1906, the US Food and Drug Administration (FDA) through regulations has been responsible for ensuring the approval of new drugs whose health benefits outweigh the known risks associated with the drug.

Continue reading “FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs” »

Predicting Adverse Event Risks and Gaining Insights from Disparate Data

Posted on May 17th, 2017 by in Pharma R&D

The upcoming Bio IT World Conference and Expo will feature two talks from Elsevier Life Sciences consultants, focusing on predicting adverse events in clinical trials and extracting knowledge from multiple data sets. Continue reading “Predicting Adverse Event Risks and Gaining Insights from Disparate Data” »

  1. 1
  2. 2
  3. 3
  4. 4